A Randomized, Double-Blind (Periods 1 to 3), Placebo- and Positive-Controlled, Single Dose, 4-Period, Crossover Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Esketamine (Primary) ; Esketamine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 27 Mar 2017 Status changed from recruiting to completed.
- 31 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Jan 2017.
- 31 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.